CLINICAL_TRIALS
trial_result
· 2009-10-30
Clinical Trial Update: Peginterferon Dose Evaluations for Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03471) [Phase 3]
Summary
Phase 3 trial evaluating peginterferon dose regimens in previously untreated chronic hepatitis C with genotype 1; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2009-10-30